Home | Welcome to Contract Pharma   
Last Updated Friday, September 19 2014
Print RSS Feed

Search Results for 'Financial Report: Johnson'

Search For:
Refine by Dates:
From: To:
Past 7 Days        Past 30 Days
Refine By Content:

Search Results:

Published July 15, 2014
Revenues up 9% in the quarter driven by new products Read More »
Published April 16, 2014
Revenues up 3% in the quarter Read More »
By Kristin Brooks
Published January 21, 2014
Pharma sales drive growth Read More »
Published April 16, 2013
Revenues up 9% in the quarter Read More »
Published July 18, 2012
Earnings drop 49% in the quarter Read More »
Published April 17, 2012
1Q Revenues: $16.1 billion (flat) 1Q Earnings: $3.9 billion (+12%) Comments: Pharma sales were $6.3 billion, up 1%, with a slight negative impact from currency rates. Consumer sales dropped 2% to $3.6 billion, as the company continues to struggle w… Read More »
Published July 14, 2009
Worldwide pharmaceutical sales were $5.5 billion in the quarter (-13%), including a 5% negative impact from currency. Read More »
Published July 17, 2007
Johnson & Johnson 2Q Revenues: $15.1 billion (+13%) 2Q Earnings: $3.1 billion (+9%) YTD Revenues: $30.2 billion (+15%) YTD Earnings: $5.7 billion (-8%) Comments: Worldwide Pharmaceutical sales were $6.1 billion in the quarter,… Read More »
Published January 23, 2007
Johnson & Johnson 4Q Revenues: $13.7 billion (+8.5%) 4Q Earnings: $2.2 billion (+3.5%) FY Revenues: $53.3 billion (+5.6%) FY Earnings: $11 billion (+10%) Comments: Worldwide pharmaceutical sales were $23.3 billion for the year… Read More »
By Gil Roth
Published July 29, 2013
Internal move could be precursor to formal split of branded, generics businesses Read More »
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On